# FDA Inspection 1255845 - Natasha Leighl, M.D. - November 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/natasha-leighl-md/c73a951a-c06b-45e2-a16a-36b1d4d906c1
Source feed: FDA_Inspections

> FDA Inspection 1255845 for Natasha Leighl, M.D. on November 22, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255845
- Company Name: Natasha Leighl, M.D.
- Inspection Date: 2024-11-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1255845 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/natasha-leighl-md/d4712d39-5577-447c-8db6-083b9b80117b)

Company: https://www.keypedia.com/companies/natasha-leighl-md/d407cb57-100b-4a87-bee1-f423da146083

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8